The Role of Unit-Dose Child-Resistant Packaging in Unintentional Childhood Exposures to Buprenorphine–Naloxone Tablets

Christian Hampp (), Maribeth C. Lovegrove, Daniel S. Budnitz, Justin Mathew, Amy Ho and Jana McAninch
Additional contact information
Christian Hampp: U.S. Food and Drug Administration
Maribeth C. Lovegrove: Centers for Disease Control and Prevention
Daniel S. Budnitz: Centers for Disease Control and Prevention
Justin Mathew: U.S. Food and Drug Administration
Amy Ho: U.S. Food and Drug Administration
Jana McAninch: U.S. Food and Drug Administration

Drug Safety, 2020, vol. 43, issue 2, No 11, 189-191

Date: 2020
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-019-00883-6 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:43:y:2020:i:2:d:10.1007_s40264-019-00883-6

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-019-00883-6

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().